26 April 2013
Instem plc
("Instem", the "Company" or the "Group")
Posting of Annual Report and Accounts
Notice of Annual General Meeting
Instem plc (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, announces that today it has posted to shareholders its Annual Report and Accounts for the year ended 31 December 2012, together with the Notice of the Annual General Meeting to be held at 12.00 noon on Tuesday 21 May 2013, at the offices of Baker Tilly UK Audit LLP, 3 Hardman Street, Manchester M3 3HF.
Copies of the Annual Report and Accounts are available on Instem's website at: http://investors.instem.com/.
For further information, please contact:
Instem plc |
+44 (0) 1785 825 600 |
Phil Reason, CEO |
|
Nigel Goldsmith, CFO
|
|
|
|
N+1 Singer (Nominated Adviser & Broker) |
+44 (0) 20 7496 3000 |
Aubrey Powell |
|
Joe Stroud
|
|
|
|
Newgate Threadneedle |
+44 (0) 20 7653 9850 |
Caroline Evans-Jones |
|
Fiona Conroy |
|
About Instem plc
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are used by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports its clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
To learn more about Instem solutions and its mission, please visit www.instem.com or its investor centre http://investors.instem.com/